In comparison to KRAS wildtype SW48 CRC epithelial cells, the KRAS mutant SW620 CRC cells used in our study demonstrated high efficiency in tumorigenic growth and secreted higher level of inflammatory chemokines such as CXCL1 and IL8. The gene discussed is KRAS; the disease is colorectal carcinoma.